480 related articles for article (PubMed ID: 27544322)
1. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[TBL] [Abstract][Full Text] [Related]
2. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[TBL] [Abstract][Full Text] [Related]
3. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
Kamrath C; Hartmann MF; Pons-Kühnemann J; Wudy SA
Metabolism; 2020 Nov; 112():154354. PubMed ID: 32916150
[TBL] [Abstract][Full Text] [Related]
4. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
5. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E; Travers S; Bouvattier C; Xue QY; Cosson C; Viengchareun S; Martinerie L; Lombès M
J Steroid Biochem Mol Biol; 2020 Apr; 198():105553. PubMed ID: 31778802
[TBL] [Abstract][Full Text] [Related]
6. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
Kamrath C; Friedrich C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2023 Jul; 231():106304. PubMed ID: 36990162
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
8. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
9. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T; Sommer G; Lang-Muritano M; Konrad D; Kuhlmann B; Zumsteg U; Flück CE
J Clin Endocrinol Metab; 2022 Jan; 107(2):e487-e499. PubMed ID: 34599587
[TBL] [Abstract][Full Text] [Related]
11. Height Velocity Defined Metabolic Control in Children With Congenital Adrenal Hyperplasia Using Urinary Steroid GC-MS Analysis.
Kamrath C; Wettstaedt L; Hartmann MF; Wudy SA
J Clin Endocrinol Metab; 2019 Sep; 104(9):4214-4224. PubMed ID: 31112272
[TBL] [Abstract][Full Text] [Related]
12. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
[TBL] [Abstract][Full Text] [Related]
13. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A; Khadilkar V; Gangodkar P; Khadilkar A
Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
[TBL] [Abstract][Full Text] [Related]
14. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Öhl L; Rauh M; Schöfl C; Dörr HG
Horm Res Paediatr; 2011; 76(6):400-10. PubMed ID: 22123283
[TBL] [Abstract][Full Text] [Related]
15. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
16. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone.
Koyama Y; Homma K; Fukami M; Miwa M; Ikeda K; Ogata T; Hasegawa T; Murata M
Clin Chem; 2012 Apr; 58(4):741-7. PubMed ID: 22273564
[TBL] [Abstract][Full Text] [Related]
17. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J; Aldridge S; Thomas M; Cheetham T
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
[TBL] [Abstract][Full Text] [Related]
18. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
19. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.
Kamrath C; Hochberg Z; Hartmann MF; Remer T; Wudy SA
J Clin Endocrinol Metab; 2012 Mar; 97(3):E367-75. PubMed ID: 22170725
[TBL] [Abstract][Full Text] [Related]
20. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
